The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care

BACKGROUND: Molecular signatures are being increasingly incorporated into cancer classification systems. DNA methylation-based central nervous system (CNS) tumor classification is being recognized as having the potential to aid in cases of difficult histopathological diagnoses. Here, we present our...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Shirin, Zuccato, Jeffrey A., Mamatjan, Yasin, Mansouri, Sheila, Suppiah, Suganth, Nassiri, Farshad, Diamandis, Phedias, Munoz, David G., Aldape, Kenneth D., Zadeh, Gelareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896594/
https://www.ncbi.nlm.nih.gov/pubmed/31806041
http://dx.doi.org/10.1186/s13148-019-0766-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896594/
https://www.ncbi.nlm.nih.gov/pubmed/31806041
http://dx.doi.org/10.1186/s13148-019-0766-2

Ejemplares similares